Main container

Studio retrospettivo su sarcomi maligni: caratterizzazione genomica e trascrittomica

Title
Studio retrospettivo su sarcomi maligni: caratterizzazione genomica e trascrittomica
Code
STRESA
Type
Studio interventistico senza dispositivi e senza farmaci
Start Year
2026
Status
In Corso

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in

Clinical Trial
A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors
Read more
Clinical Trial
Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors
Read more
Content updated
16/10/2026 16:50